122 related articles for article (PubMed ID: 18199587)
1. Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin.
Kopp UC; Cicha MZ; Yorek MA
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R858-66. PubMed ID: 18199587
[TBL] [Abstract][Full Text] [Related]
2. Activation of endothelin-a receptors contributes to angiotensin-induced suppression of renal sensory nerve activation.
Kopp UC; Cicha MZ; Smith LA
Hypertension; 2007 Jan; 49(1):141-7. PubMed ID: 17060503
[TBL] [Abstract][Full Text] [Related]
3. Endogenous angiotensin modulates PGE(2)-mediated release of substance P from renal mechanosensory nerve fibers.
Kopp UC; Cicha MZ; Smith LA
Am J Physiol Regul Integr Comp Physiol; 2002 Jan; 282(1):R19-30. PubMed ID: 11742819
[TBL] [Abstract][Full Text] [Related]
4. Impaired substance P release from renal sensory nerves in SHR involves a pertussis toxin-sensitive mechanism.
Kopp UC; Cicha MZ
Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R326-33. PubMed ID: 14578115
[TBL] [Abstract][Full Text] [Related]
5. Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin.
Kopp UC; Cicha MZ; Smith LA
Am J Physiol Regul Integr Comp Physiol; 2003 Jan; 284(1):R116-24. PubMed ID: 12388453
[TBL] [Abstract][Full Text] [Related]
6. Impaired interaction between efferent and afferent renal nerve activity in SHR involves increased activation of alpha2-adrenoceptors.
Kopp UC; Cicha MZ; Smith LA
Hypertension; 2011 Mar; 57(3):640-7. PubMed ID: 21263127
[TBL] [Abstract][Full Text] [Related]
7. Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve fibers.
Kopp UC; Cicha MZ; Smith LA; Mulder J; Hökfelt T
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1561-72. PubMed ID: 17699565
[TBL] [Abstract][Full Text] [Related]
8. Dietary sodium modulates the interaction between efferent and afferent renal nerve activity by altering activation of α2-adrenoceptors on renal sensory nerves.
Kopp UC; Cicha MZ; Smith LA; Ruohonen S; Scheinin M; Fritz N; Hökfelt T
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R298-310. PubMed ID: 21106912
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of endothelin on activation of renal mechanosensory nerves: stimulatory in high-sodium diet and inhibitory in low-sodium diet.
Kopp UC; Cicha MZ; Smith LA
Am J Physiol Regul Integr Comp Physiol; 2006 Nov; 291(5):R1545-56. PubMed ID: 16763077
[TBL] [Abstract][Full Text] [Related]
10. Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory nerves in congestive heart failure.
Kopp UC; Cicha MZ; Jones SY
Can J Physiol Pharmacol; 2010 Jun; 88(6):622-9. PubMed ID: 20628427
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP.
Kopp UC; Cicha MZ; Smith LA
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F472-83. PubMed ID: 12746258
[TBL] [Abstract][Full Text] [Related]
12. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
[TBL] [Abstract][Full Text] [Related]
13. PGE2 increases substance P release from renal pelvic sensory nerves via activation of N-type calcium channels.
Kopp UC; Cicha MZ
Am J Physiol; 1999 May; 276(5):R1241-8. PubMed ID: 10233013
[TBL] [Abstract][Full Text] [Related]
14. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.
Castoldi G; di Gioia CRT; Roma F; Carletti R; Manzoni G; Stella A; Zerbini G; Perseghin G
Acta Diabetol; 2019 Jan; 56(1):97-104. PubMed ID: 30187136
[TBL] [Abstract][Full Text] [Related]
15. Dietary sodium modulates the interaction between efferent renal sympathetic nerve activity and afferent renal nerve activity: role of endothelin.
Kopp UC; Grisk O; Cicha MZ; Smith LA; Steinbach A; Schlüter T; Mähler N; Hökfelt T
Am J Physiol Regul Integr Comp Physiol; 2009 Aug; 297(2):R337-51. PubMed ID: 19474389
[TBL] [Abstract][Full Text] [Related]
16. Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes.
de Cavanagh EM; Ferder L; Toblli JE; Piotrkowski B; Stella I; Fraga CG; Inserra F
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H456-65. PubMed ID: 18024545
[TBL] [Abstract][Full Text] [Related]
17. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
[TBL] [Abstract][Full Text] [Related]
18. PGE(2) increases release of substance P from renal sensory nerves by activating the cAMP-PKA transduction cascade.
Kopp UC; Cicha MZ; Smith LA
Am J Physiol Regul Integr Comp Physiol; 2002 Jun; 282(6):R1618-27. PubMed ID: 12010743
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
20. Renal substance P-containing neurons and substance P receptors impaired in hypertension.
Kopp UC; Cicha MZ; Farley DM; Smith LA; Dixon BS
Hypertension; 1998 Mar; 31(3):815-22. PubMed ID: 9495266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
